• Featured Product
  • KD/KO Validated

IFITM2/3 Monoklonaler Antikörper

IFITM2/3 Monoklonal Antikörper für WB, IHC, IF/ICC, ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, ELISA

Konjugation

Unkonjugiert

CloneNo.

2E8D12

Kat-Nr. : 66081-1-PBS

Synonyme

IFITM3, 1 8U, 2E8D12, DSPA2b, Interferon-induced transmembrane protein 3



Geprüfte Anwendungen

Produktinformation

66081-1-PBS bindet in WB, IHC, IF/ICC, ELISA IFITM2/3 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen IFITM2/3 fusion protein Ag17863
Vollständiger Name interferon induced transmembrane protein 3 (1-8U)
Beobachtetes Molekulargewicht 15-20 kDa
GenBank-ZugangsnummerBC070243
Gene symbol IFITM3
Gene ID (NCBI) 10410
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

IFITM3, also named as interferon-inducible protein 1-8U, belongs to the CD225 family. It is IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus, by inhibiting the early steps of replication. IFITM3 is identified as interferon-induced cellular proteins that restrict infections by retroviruses and filoviruses and of influenza virus and flaviviruses, respectively. IFITM3, the most potent antiviral IFITM, was found to inhibit an uncharacterized early infectious event after VSV endocytosis, but before primary transcription of its viral genome. IFITM proteins are viral restriction factors that can inhibit infection mediated by the influenza A virus (IAV) hemagglutinin (HA) protein. They differentially restrict the entry of a broad range of enveloped viruses, and modulate cellular tropism independently of viral receptor expression. This antibody recognizes both IFITM2 and IFITM3.